CLINICAL TRIALS PROFILE FOR QELBREE
✉ Email this page to a colleague
All Clinical Trials for qelbree
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT06185985 ↗ | Open-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms | Recruiting | Supernus Pharmaceuticals, Inc. | Phase 4 | 2024-03-01 | Open label, flexible dose, decentralized clinical trial evaluating the efficacy and safety of SPN-812 in adults with ADHD and mood symptoms. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for qelbree
Condition Name
Clinical Trial Locations for qelbree
Trials by Country
Clinical Trial Progress for qelbree
Clinical Trial Phase
Clinical Trial Sponsors for qelbree
Sponsor Name